Abstract:Kang-Xin Li, 1, &ast Hui Yuan, 1, &ast Jing Zhang, 2, 3 Xiao-bin Peng, 1 Wei-Fen Zhuang, 1 Wen-Tao Huang, 1 Hui-Xin Liang, 1 Ying Lin, 1 Ying-Zhen Huang, 1 Shu-Lan Qin 1 1 Department of Endocrinology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, People's Republic of China; 2 State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, 330004, People's Republic of China; 3 China Resources Jiangzhong Pharmaceutical Group Co., Ltd., Nanchang, Jiangxi, 330004, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shu-Lan Qin, Email Introduction: Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterised by insulin resistance, hyperglycaemia, and inflammation, with oxidative stress contributing to its progression. Curcumin (CUR), known for its anti-inflammatory, antioxidant, and insulin sensitising effects, has shown potential for the treatment of T2DM but is limited by low solubility and bioavailability. This study investigated long-circulating curcumin-loaded liposomes (CUR-LPs) to improve curcumin stability, solubility, and circulation and assessed their effect on insulin resistance in a murine model of T2DM. Methods: CUR-LPs were prepared using the ethanol injection method and characterized for morphology, particle size, zeta potential, encapsulation efficiency, drug-loading capacity, and in vitro release. Cell viability was tested on murine L929 cells. In a T2DM murine model, after four weeks of CUR-LP treatment, inflammatory markers TNF-α and IL-6 were measured by real-time polymerase chain reaction, and liver tissues were analyzed for glutathione (GSH) and superoxide dismutase (SOD) via colorimetry. Results: CUR-LPs were spherical, with an average diameter of (249 ± 2.3) nm and a zeta potential of (− 33.5 ± 0.8) mV. They exhibited an encapsulation efficiency of (99.2 ± 0.5) %and a drug-loading capacity of (1.63 ± 0.02) %. CUR embedding in liposomes significantly maintained CUR release. In L929 cells, over 80% viability was maintained at 12 uM CUR concentration after 24 h. In HFD/STZ-induced T2DM mice, CUR-LPs improved blood glucose and insulin levels more efficiently than free CUR, and CUR-LPs also reduced hepatic inflammation (TNF-α, IL-6), enhanced hepatic GSH and SOD, and attenuated liver injury. Conclusion: CUR-LPs improved glucose metabolism and insulin resistance in HFD/STZ-induced T2DM mice, which may be associated with a decrease in liver inflammation and oxidative stress. Keyworks: T2DM, curcumin, liposomes, insulin resistance, glucose metabolism, oxidative stress Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion and/or insulin action, with Type 2 diabetes mellitus (T2DM) accounting for 90–95% of diabetes patients. 1 T2DM is a metabolic disease characterized by hyperglycemia and occurs due to a variety of complex physiological and pathological processes, with insulin resistance being a hallmark characterizing. 2 Insulin resistance has a complex pathology, which is promoted by multiple factors, including inflammation and oxidation stress. 3 Inflammation and insulin resistance are closely related, and inflammatory cytokines such as TNF-α and IL-6 can inhibit insulin signaling through various mechanisms. 4 Along with inflammation, oxidative stress is also a key factor in the development of insulin resistance and T2DM. High blood glucose levels produce reactive oxygen species, which are key contributors to oxidative stress. 5 Curcumin (CUR) is a polyphenol with a relatively small molecular mass and is the most effective ingredient in turmeric, can activate multiple cell signal pathways in the body, inhibit the formation of advanced glycation end products, reduce the generation of inflammatory factors, and show antioxidant stress effects, thereby protecting islet βcells, improving glucose metabolism, and combating insulin resistance. 6 In addition, previous studies have shown that CUR can improve blood lipid levels, stimulate the antioxidant defense mechanism, and improve mitochondrial dysfunction. 7 Studies have shown that the main active ingredients of turmeric have a significant treatment effect on diabetes. 8 However, CUR has poor water solubility, is easily oxidized in vitro, has low bioavailability, and is metabolized rapidly. Therefore, CUR as a therapeutic agent has greatly limited its clinical applicat -Abstract Truncated-

Curcumin metabolites contribute to the effect of curcumin on ameliorating insulin sensitivity in high-glucose-induced insulin-resistant HepG2 cells

Protective Effect Of Curcumin Against High Glucose-Induced Endoplasmic Reticulum Stress By Downregulation Of Cox-2 Expression In Human Umbilical Vein Endothelial Cells

Curcumin Ameliorates High Glucose-Induced Dysfunction of Vasoconstriction Via Heme Oxygenase-1 and GC Pathway

Curcumin Protects Against Glucose‐induced Endothelial Dysfunction Through HO‐1 and GC Pathway

Curcumin-Loaded Long-Circulation Liposomes Ameliorate Insulin Resistance in Type 2 Diabetic Mice

Dietary curcumin enhances insulin clearance in diet-induced obese mice via regulation of hepatic PI3K-AKT axis and IDE, and preservation of islet integrity

Curcumin improves high glucose-induced INS-1 cell insulin resistance via activation of insulin signaling

Curcumin and insulin resistance-Molecular targets and clinical evidences

Curcumin improves insulin sensitivity in high-fat diet-fed mice through gut microbiota

Curcumin Rescues High Fat Diet-Induced Obesity and Insulin Sensitivity in Mice Through Regulating SREBP Pathway.

Curcumin Improved Glucose Intolerance, Renal Injury, and Nonalcoholic Fatty Liver Disease and Decreased Chromium Loss through Urine in Obese Mice

Counteracting Action of Curcumin on High Glucose-Induced Chemoresistance in Hepatic Carcinoma Cells

Network Pharmacology Integrated With Quantum‐Polarized Ligand Docking and Molecular Simulation Revealed the Anti‐Diabetic Potential of Curcumin

Curcumin anti-diabetic effect mainly correlates with its anti-apoptotic actions and PI3K/Akt signal pathway regulation in the liver

The effect of curcumin on PI3K/Akt and AMPK pathways in insulin resistance induced by fructose

Targeted Screening of Curcumin Derivatives as Pancreatic Lipase Inhibitors Using Computer-Aided Drug Design

Therapeutic Role of Curcumin in Diabetes: An Analysis Based on Bioinformatic Findings

Ameliorative Effects of Curcumin on Type 2 Diabetes Mellitus

Curcumin alleviates lipid deposition in hepatocytes through miR-3666/ AMPK axis regulation

Potential Effect of Curcumin in Lowering Blood Glucose Level in Streptozotocin-Induced Diabetic Rats

Dietary curcumin restores insulin homeostasis in diet-induced obese aged mice